- Home » News and EventsPage 34
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent To Discuss Potential Implications of Brexit on Clinical Supply
Mar 8, 2018
Catalent To Discuss Potential Implications of Brexit on Clinical Supply. SOMERSET, N.J. – March 8, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and d…
Catalent Institute to Host Discussion on Patient-Focused Drug Design
Mar 1, 2018
The Catalent Applied Drug Delivery Institute today announced that it is to hold a one-day symposium titled “Smart Drug Development & Design from Candidate to Phase I” on Thursday, March 8, at Novartis…
Catalent Completes $4.6 Million Expansion at Singapore Facility
Feb 28, 2018
SOMERSET, N.J. & PHAR-EAST, Singapore – February 28, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and …
Catalent to Present at Clinical Trial Supply New England
Feb 22, 2018
Catalent to Present at Clinical Trial Supply New England. SOMERSET, N.J. – February 22, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development …
Biohaven Announces Exclusive License with Catalent for Zydis® ODT
Feb 21, 2018
(NYSE: CTLT) (“Catalent”) to provide Catalent’s Zydis® ODT (orally disintegrating tablet) fast-dissolving formulation for the development of Biohaven’s lead calcitonin-gene related peptide (CGRP) anta…
Catalent Recognized with 10 CMO Leadership Awards
Feb 5, 2018
Catalent Recognized with 10 CMO Leadership Awards. SOMERSET, N.J. – February 5, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solution…
Catalent Biologics to Present at CASSS WCBP Symposium
Jan 29, 2018
SOMERSET, N.J. – January 29, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products…
Triphase to Present IND Enabling Data for TRPH-222
Dec 4, 2017
Triphase to Present IND Enabling Data for TRPH-222. Toronto, Ontario, and Somerset, N.J. – December 4, 2017 – Triphase Accelerator Corporation, a company dedicated to acquiring and developing novel th…
Vaccinex and Catalent Biologics to Collaborate on ADC Development
Nov 30, 2017
Vaccinex and Catalent Biologics to Collaborate on ADC Development. – November 30, 2017 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development soluti…
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.